Interestingly, while IDC + DCIS was associated with improved survival for patients who were (1) ER or PR positive and Her2 negative or (2) Her2 positive, this was not seen for patients with triple negative disease (Supplementary Fig. 1). Here, ESR1 is linked to ductal breast carcinoma in situ.